Title : The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trial.

Pub. Date : 2021 Sep 3

PMID : 34480075






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The vasopressin V2 receptor antagonist tolvaptan delays the progression of autosomal dominant polycystic kidney disease (ADPKD). Tolvaptan arginine vasopressin receptor 2 Homo sapiens